Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

56 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Preparation of polysaccharide-conjugate vaccines.
Peeters CC, Lagerman PR, de Weers O, Oomen LA, Hoogerhout P, Beurret M, Poolman JT, Reddin KM. Peeters CC, et al. Among authors: hoogerhout p. Methods Mol Med. 2003;87:153-74. doi: 10.1385/1-59259-399-2:153. Methods Mol Med. 2003. PMID: 12958455 No abstract available.
Synthetic trimer and tetramer of 3-beta-D-ribose-(1-1)-D-ribitol-5-phosphate conjugated to protein induce antibody responses to Haemophilus influenzae type b capsular polysaccharide in mice and monkeys.
Peeters CC, Evenberg D, Hoogerhout P, Käyhty H, Saarinen L, van Boeckel CA, van der Marel GA, van Boom JH, Poolman JT. Peeters CC, et al. Among authors: hoogerhout p. Infect Immun. 1992 May;60(5):1826-33. doi: 10.1128/iai.60.5.1826-1833.1992. Infect Immun. 1992. PMID: 1563770 Free PMC article.
Preparation, antigenicity, and immunogenicity of synthetic ribosylribitol phosphate oligomer-protein conjugates and their potential use for vaccination against Haemophilus influenzae type b disease.
Evenberg D, Hoogerhout P, van Boeckel CA, Rijkers GT, Beuvery EC, van Boom JH, Poolman JT. Evenberg D, et al. Among authors: hoogerhout p. J Infect Dis. 1992 Jun;165 Suppl 1:S152-5. doi: 10.1093/infdis/165-supplement_1-s152. J Infect Dis. 1992. PMID: 1588151
Second generation meningococcal OMP-LPS vaccines.
Poolman JT, van der Ley PA, Wiertz EJ, Hoogerhout P. Poolman JT, et al. Among authors: hoogerhout p. NIPH Ann. 1991 Dec;14(2):233-41. NIPH Ann. 1991. PMID: 1725922 No abstract available.
Polysaccharicb-conjugate vaccines.
Peeters CC, Lagerman PR, de Weers O, Oomen LA, Hoogerhout P, Beurret M, Poolman JT. Peeters CC, et al. Among authors: hoogerhout p. Methods Mol Med. 1996;4:111-33. doi: 10.1385/0-89603-334-1:111. Methods Mol Med. 1996. PMID: 21359698
Epitope specificity of murine and human bactericidal antibodies against PorA P1.7,16 induced with experimental meningococcal group B vaccines.
Rouppe van der Voort EM, Kuipers B, Brugghe HF, van Unen LM, Timmermans HA, Hoogerhout P, Poolman JT. Rouppe van der Voort EM, et al. Among authors: hoogerhout p. FEMS Immunol Med Microbiol. 1997 Mar;17(3):139-48. doi: 10.1111/j.1574-695X.1997.tb01006.x. FEMS Immunol Med Microbiol. 1997. PMID: 9093834 Free article. Clinical Trial.
56 results